ACE inhibitor and calcium channel blocker combination

0 marketed 1 in Phase 3

This page covers all ACE inhibitor and calcium channel blocker combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ACE (angiotensin-converting enzyme) and L-type voltage-gated calcium channels.

Targets

ACE (angiotensin-converting enzyme) and L-type voltage-gated calcium channels

Phase 3 pipeline (1)

Patent intelligence